From drug target to lead molecules — computational solutions in translational research

webinar

Mon, 02 Dec 2013, 17:00 CET (Berlin)

From drug target to lead molecules — computational solutions in translational research

Turning early stage discoveries in cell and molecular biology into small molecule tool compounds and drug-like leads is a significant challenge, especially when resources are limited. We will show how you can fast-track your translational research using computational tools to analyze targets, hunt for data, identify potential small molecule binding pockets, and find active molecules. Leverage your know-how and take the first steps in drug discovery with us!

Current news

category
Events
Boston Event: Expanding Molecular Diversity with CORE
September 15, 2026 17:27 CEST
Chemical Space Exploration Meets AI in Boston BioSolveIT and Onepot.AI invite you to an evening of science, drinks, and conversation at D16, the speakeasy beneath Dillon’s in Boston. Join us on September 30, 2026, for two very concise presentations exploring how ultra-large Chemical Spaces and artificial intelligence can open new...
Read on
category
Events
Beyond the Flatland: sp³-Rich Fragments Unlock Novel Kinase Chemotypes: Free Webinar!
September 15, 2026 10:40 CEST
Kinases are among the most intensively pursued target families in drug discovery, yet the chemical matter screened against them remains surprisingly narrow. Conventional kinase-focused libraries are dominated by flat, heteroaromatic compounds, while saturated, three-dimensional molecules stay largely underexplored. That narrow structural diversity makes it harder to find genuinely novel chemotypes,...
Read on
LifeCheMyriads by Life Chemicals - Access now with our tools
August 31, 2026 09:39 CEST
LifeCheMyriads brings an actionable, novelty-focused universe of 53 billion on-demand synthesizable compounds directly into your workflow. Created by Life Chemicals, this collection was built from 210 in-house-validated reaction protocols and 20,000+ proprietary and commercially available building blocks. The result is a medicinal chemistry-driven catalog spanning more than 340 million unique...
Read on